The Study On The Establishment Of China’s Orphan Drug Policy

OBJECTIVE:The purpose of this study is the understanding of China’s rare disease and orphan drug status,The establishment of orphan drugs policy recommendations by analyzing the international orphan drug policies and regulations,drawing on the successful experience of international orphan drug management system.METHODS:In the draw on the basis of previous literature search method to collect a wide range of knowledge and materials,The use of description, comparison,analysis of research methods.Description of rare diseases and orphan drugs, rare diseases and orphan drugs policy of the countries, the countries of the Orphan Drug Research; Compared to different Nationals orphan drug policy in order to be able to draw targeted management model;Describe and compare objectively the status of rare diseases and orphan drugs,and then by the analysis method to reach a final conclusion.Broader content of this study, but indirectly related to most of the content, subject to certain treatment concluded,therefore,the analysis method is the most important research in this article.RESULT:Analysis of a rare disease and orphan drug situation and the problems, Study abroad orphan drugs policy management system, analysis of foreign preferential policies on orphan drugs R&D,combined with the problems of China’s orphan drug research and development for China to establish an orphan drug policy referencerecommendations.CONCLUSIONS:China should actively implement preferential policies to promote the development of orphan drugs,improve the Orphan Drug Policy;rare disease prevention and control capacity,and strict prenatal diagnosis,and improve the understanding of the medical staff in order to protect the equal right to medical treatment of the rare patients,to give equal social rights.